A major breakthrough in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently inactivated in various forms of malignancies, causing https://bookmarklinkz.com/story21857581/nanobodies-reactivate-the-p53-protein-new-promising-pathway-for-malignant-treatment